Smarter Manufacturing. Faster Outcomes. Greater Control.

At MedPharm, we believe that innovation in pharmaceutical manufacturing is not solely about speed; it’s about creating smarter, safer, and more reliable processes. That’s why we are advancing the future of drug product development through Continuous Flow and Continuous Process Technologies, which are designed to improve efficiency, reduce variability, and strengthen compliance throughout the lifecycle of topical and transdermal products.   

Whether you are developing a complex semisolid formulation or preparing for a commercial launch, MedPharm applies the principles of continuous processing to ensure precise control, real-time insights, and scalable performance.  

What is Continuous Processing?

Unlike traditional batch methods, continuous processes allow for uninterrupted manufacturing, with raw materials being fed, transformed, and output in a consistent flow. This approach offers several significant advantages:  

• Greater process control and repeatability  

• Faster time-to-market and reduced cycle times  

• Smaller equipment footprints and minimized material waste  

• Improved scalability from development to commercialization  

• Enhanced product quality with real-time analytics (PAT-ready) 

For pharmaceutical products—especially those with narrow specifications or complex rheological behavior—continuous processing provides the precision and adaptability needed to meet the highest quality standards.   

MedPharm’s Capabilities in Continuous Technologies

While continuous flow has been primarily associated with small-molecule synthesis, MedPharm applies these technologies across formulation development, analytical method development, and the manufacturing of topical and transdermal dosage forms. Our current capabilities include:  

Continuous Emulsion and Gel Formation: For creams, lotions, ointments, and gels with consistent particle distribution and rheology.  

Inline Mixing & Real-Time Monitoring: For uniform incorporation of APIs, excipients, and stabilizers with reduced manual intervention.  

Process Analytical Technology (PAT) Integration: To track critical process parameters (CPPs) and ensure consistent critical quality attributes (CQAs).  

Feasibility & Scale-Up Studies: Evaluating the impact of continuous versus batch production for your specific formulation needs.  

Support for Hybrid Processes: Combining continuous and batch elements to maximize process flexibility and throughput. 

Innovate Without Compromise

Continuous flow and continuous process technologies offer transformative potential for pharmaceutical manufacturing. At MedPharm, we help you unlock that potential while ensuring the rigor, compliance, and product quality that your patients and regulators demand.